Ensuring the citation data we collect at CiteAb is comprehensive and of high-quality is central to our mission of using data to accelerate science.
That’s why we are thrilled to partner with Springer Nature, a global publishing company who place emphasis on advancing discovery and making the research cycle simpler.
Our partnership will allow researchers and suppliers to unlock value from Springer Nature’s previously hidden content, through our products and both of our platforms.
How will the Springer Nature – CiteAb partnership work?
This partnership provides CiteAb with new access to Springer Nature Protocols and Method content. Our data collection workflow, involving proprietary text mining technology and extensive human reviewing, will be applied to this content.
The citation data collected will be fed back into our search engine for researchers, which ranks reagents by citations. Experimental information will be extracted from the publications and used to give further information on CiteAb product pages.
This extra citation data which powers our data products will be able to be utilised by suppliers, including in citation and image provision and market data.
On top of this, we will be providing our high quality citation data back to Springer Nature to enable them to help the researchers using their platform.
How will this impact researchers?
The data from Springer Nature Protocols and Methods papers will improve our reagent search for researchers.
This portfolio covers more than 78,000 articles, with Springer Protocols as the oldest and longest running protocols publication series. As of 2021, the four publications had more than 12 million downloads globally.
The CiteAb search fundamentally changes the way researchers find reagents that work, by providing access to essential information such as reagent classifications, published images and application information. We consistently work to expand the data we mine to help researchers who use the search. Through this partnership we are making significant steps in this direction, adding citations and experimental information from Springer Nature publications.
This informative, high quality content added to the search will translate into more informed purchasing decisions for researchers, streamlining the research process.
By purchasing the right reagent, a significant amount of time and money is saved in life science. A massive amount of funding is spent on reagents, with $2.5 billion spent annually on antibodies alone . When the wrong research reagent is purchased this equates to wasted funds for researchers, as well as significant opportunity costs.
CiteAb CEO Andrew Chalmers said of the partnership:
‘‘At CiteAb we are committed to ensuring our citation data helps in advancing science, mirroring Springer Nature’s commitment to advancing discovery through their work. Not only that, but their focus on high quality science aligns with our focus on high quality data. We can’t wait to see the benefits of leveraging our technology to bring the value of Springer Nature publications to even more researchers and suppliers in this really exciting new step for both of us!”
How will this impact suppliers?
Suppliers will find further valuable insights in the citation data added from Springer Nature publications.
The market data CiteAb provides can help suppliers in developing products for research, their strategic business decisions and marketing and sales efforts by giving a more thorough understanding of how products have been used. Access to further citations will enrich the data CiteAb provides.
Citation and image provision will also see improvements, as more citations are uncovered for products used in life science. This may help suppliers to improve their product offering, helping many more researchers!
On top of this, researchers will be able to see more instances of supplier products being used when using our search engine, providing suppliers with further exposure. The CiteAb search has over 60,000 users a month and amassed nearly half a million searches last year.
Robin Padilla, Ph.D., Director of Product Management, Digital Life Science Solutions at Springer Nature said of the partnership:
“We are delighted to be the first publisher to partner with CiteAb. We see clear synergies between us both on how we utilise the resources we have to make researchers’ lives simpler and support them in the advancement of science. There are millions of reagents across the life sciences and as such it can be incredibly time consuming for researchers to find what is most suitable for their work, in a timely fashion, and to know that the data and products they are using work and can be trusted. Combining our high quality data and content, with CiteAb’s innovative platform and search functionality, we aim to find a solution to help address that challenge for researchers.”
We are really excited to see the impact of this partnership, and continue forging partnerships with publishers to together help the scientific community advance research.
“What is exciting is that this is only the first stage of the partnership, and we are excited to see how it can be expanded and developed to bring new benefits from combining our text mining, Springer Nature’s content and both our platforms. We see huge potential for accelerating science!”
Look out for future updates on how this partnership progresses!
Read more about our partnership here.
- Skye and the CiteAb team
 Quality testing for antibodies is gaining traction. (n.d.). www.nature.com. [online] Available at: https://www.nature.com/articles/d42473-018-00082-4.